Archive for Tuesday, May 4, 2010

Deciphera may receive almost $400K from KBA for cancer research work

May 4, 2010

Advertisement

Deciphera Pharmaceuticals could receive a $390,000 boost for cancer research from the Kansas Bioscience Authority.

On Monday, the KBA investment committee recommended supporting the Lawrence-based company as part of the KBA’s research and development voucher program, which is designed to give early-stage support for projects that have both high potential and high risk. The committee’s recommendations will be passed on to the entire KBA board.

Deciphera would make a $1.75 million match to KBA’s $390,000 investment. The money would help finance three programs that are researching cancer-fighting drugs specific to protein kinases. Deciphera will work with two other Kansas companies: Xenometrics in Stilwell and Xenotech in Lenexa.

This is the first time that Deciphera has asked the KBA for support, said Michael Rafferty, Deciphera’s vice president of pre-clinical development.

The KBA’s investment committee also agreed to support another cancer project. The committee recommended giving almost $250,000 for the Kansas University Cancer Center to study how Omega-3 fatty acids could help prevent breast cancer in premenopausal women.

The project will look at whether Omega-3 fatty acids can change cellular and molecular risk indicators in breast tissue and blood and whether they can reduce actual cases of breast cancer in animals.

As of now, tamoxifen is the only FDA-approved drug that reduces the risk for breast cancer. But that drug comes with side effects.

KU professor of hematology and oncology Carol Fabian, the lead researcher on the project, said healthy women aren’t interested in taking drugs that come with side effects. But they are willing to take natural food products and additives to prevent breast cancer.

Comments

puddleglum 5 years, 1 month ago

standard lawrence good ol' boy procedure

Brent Fry 5 years, 1 month ago

I love it when uninformed people like KRichards make comments on subjects they know absolutely nothing about

cnk0330 4 years, 10 months ago

As far as I know about deciphera, this company is more business driven rather than science oriented. I would not be surprised by the comments made from KRichards even when deciphera made good deal with Eli Lilly 2 years ago.

Boston_Corbett 5 years, 1 month ago

Puddle: How is obtaining a competitive grant from a state board with some national, and no Lawrence, residents, standard Lawrence good ol' boy procedure?

nobody1793 5 years, 1 month ago

  1. No, the number of cars parked there has not dropped dramatically.
  2. Point 1 is moot since most of the parking there is KU related anyway.

bookemdano 5 years, 1 month ago

lawrenceguy40, do you actually read this newspaper? If so then you would have known that Deciphera moved its corporate offices downtown in the last year, which obviously would result in less cars parked at their facility on Wakarusa.

Maybe try a little research before hitting the "Post" button.

nobody1793 5 years ago

KU owns all three buildings, and Deciphera only leases about 1/6 of that space. But no, you don't have to have a parking sticker there.

Steve Jacob 5 years ago

One thing I have learned from watching CNBC is these pharmaceutical companies are so risk/reward, it's crazy. You spend millions on a drug that does not get FDA approval, the bottom falls out.

Commenting has been disabled for this item.